News
-
Cedars-Sinaï praises Confocal Laser Endomicroscopy
Jeffrey Conklin, MD and Laith H. Jamil, MD publish some case studies in the Cedars-Sinaï Medical Center GI Newsletter to illustrate how the Cellvizio technology "gives GIs a powerful new tool". Download the PDF
31/01/2010
more
-
Cellvizio benefits patients at Yale
Dr. Jamidar is one of the doctors using Cellvizio at Yale-New Haven. He describes in a press release the improvements brought by Cellvizio on the diagnostic and treatment processes of gastrointestinal cancers and diseases.
Download the PDF
15/01/2010
more
-
University of Virginia Health System adopts Cellvizio
Dr. Michel Kahaleh, Division of Gastroenterology and Hepatology at the University of Virginia Health System, describes in a press release the performance of Cellvizio, which represents for him "the future of medicine". Download the PDF
15/01/2010
more
-
Cellvizio used at the VA Palo Alto in urology
Dr. Joseph Liao talks in an interview on KGO Channel 7 about how Cellvizio can improve his research on cancer by providing a new technology of cellular imaging.07/01/2010
more
-
Cellvizio featured on ABC affiliate KOMO TV in Seattle
Dr. Michael Saunders, from the University of Washington Medical Center explains on KOMO TV how he uses Cellvizio for real time microscopic observation of cells and talks about its benefits for patients suffering from Barrett's esophagus.25/10/2009
more
-
Cellvizio at University of Chicago Hospitals
Cellvizio is featured as "Miniature microscope [that] can improve disease detection, diagnosis and treament", on University of Chicago Medical Center's website.21/10/2009
more
-
Cellvizio at the University of Washington's Medical Center
Read the article published in SeattlePi about "one of the world's smallest microscopes" used by Dr. Michael Saunders at the University of Washington's Medical center. The article is linked on UW Medicine web site as well.21/10/2009
more
-
Princess Caroline inaugurates Cellvizio at Princess Grace Hospital
The hospital's Hepato-Gastroenterology Department, one of the best in Europe, has been equipped with Cellvizio. The inauguration took place on September 10th, in presence of Her Royal Highness the Princess Caroline of Hanover.12/09/2009
more
-
29/11/2013
Endo-Update
Endo-update 2013 is a two-day interventional endoscopy update course in Augsburg, Germany, with an internationally recognized faculty highlighting the latest research, skills, and technologies with simultaneous live sessions, state-of-the-art lectures, case discussions and interactive case presentations. More details to come soon !more
-
18/09/2013
WMIC Meeting 2013 Savannah
The World Molecular Imaging Congress is organized by the joint efforts of the “World Molecular Imaging Society – WMIS“, the “European Society for Molecular Imaging – ESMI” and the “Federation of Asian Societies for Molecular Imaging – FASMI“. The WMIC is led by the senior academic and industry professionals who have widely recognized expertise in molecular imaging. The scientific sessions held at the conference cover a broad spectrum of basic and translational sciences (pre-clinical to clinical) forming a Discovery-to-Delivery (D2D) process that helps facilitate academic and industrial partnerships. Through innovation, our goal is to optimize the D2D efforts leading to new medical and molecular imaging discoveries, greater linkages between research and market outcomes, and significant improvements in healthcare. Comme visit us and discover Cellvizio Dual Band for translational research!more
See all events
-
17/06/2013
CELLVIZIO DAY : TRAINING WORKSHOP AT PAOLI CALMETTES INSTITUTE - MARSEILLE, FRANCE
Acquire a basic understanding of how the Cellvizio system works, and learn how to interpret Cellvizio images of the esophagus, bile duc and colon. Live cases will be observed and the latest clinical data and case studies will be analyzed.
See all training opportunities
-
07/05/2013
Cellvizio News, May 2013
FDA grants Mauna Kea Technologies 510(k) clearance to market AQ-Flex™19 miniprobe for fine needle aspiration procedures Mauna Kea Technologies announced that the U.S. Food and Drug Administration (FDA) has cleared the AQ‐Flex™ 19 miniprobe to provide real‐time optical biopsies during endoscopic ultrasound‐guided fine needle aspiration (EUSFNA) procedures in the digestive tract. This represents the sixth U.S. regulatory clearance for Mauna Kea Technologies’ Cellvizio on one of its dedicated miniprobes, which already obtained the CE mark in Europe.more
See all newsletters
-
13/06/2013
MAUNA KEA TECHNOLOGIES ENTERS INTO MAJOR CELLVIZIO® DISTRIBUTION AGREEMENT WITH A LEADING JAPANESE MEDICAL DEVICE COMPANY
PARIS, (June 13, 2013) – Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, reported that it has entered an exclusive distribution agreement in Japan with AMCO Inc. for a five-year period. This partnership further strengthens Mauna Kea Technologies’ ties with the Japanese market, and is a major step forward in the company’s efforts to obtain regulatory approval in the world’s second largest endoscopy device market after the US. The Japanese Ministry of Health, Labor, and Welfare (MHLW) requires foreign medical device companies to have a physical presence within the country or define a partnering distributor prior to approving a device for commercial sale.
Read all our press releases
